background previous studies vitamin d binding protein vdbp known component gc encoded gc gene implicated gene variants gc2 gc1f possible contributors chronic obstructive pulmonary disease copd protection susceptibility respectively objective study examine association vdbp different subtypes copd study design association various gc genotypes copd phenotype examined icelandic copd patients followed pulmonary physicians university hospital iceland methods patients genotyped known alleles gc gene single nucleotide polymorphisms snps identified restriction fragment length polymorphism procedure study power estimated based allele frequencies variants risk ratios calculated prevalence genotypes affected group divided prevalence control population statistical analyses performed using fishers exact test chi2 test appropriate patient group copd patients NUMBER controls NUMBER asthma patients NUMBER patients chronic mucous hypersecretion cmh examined main outcome measure results results demonstrate similar allele genotype frequencies gc copd patients overall healthy controls higher prevalence genotypes carrying gc1f allele lower prevalence genotypes gc2 allele cmh patients controls difference notable homozygous form NUMBER vs NUMBER NUMBER vs NUMBER genotypes respectively controlled smoking cmh patients demonstrated significantly altered frequency genotype p NUMBER prevalence genotype significantly lower patients bronchial hypersecretion airflow obstruction compared control group NUMBER vs NUMBER taken results demonstrate gc1f gc2 alleles associated sputum hypersecretion individuals increased risk developing copd group specific NUMBER tailed non smoking gc1f 1f gc2 NUMBER gc1f 1f gc2 NUMBER